Status:
UNKNOWN
Smoking Cessation in Cancer Treatment
Lead Sponsor:
Norwegian Institute of Public Health
Collaborating Sponsors:
Norwegian Cancer Society
Helse Stavanger HF
Conditions:
Smoking Cessation
Motivation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The intervention to be studied is a smoking cessation program offered to newly diagnosed cancer patients at their first consultation for treatment at an oncological hospital department.
Detailed Description
The theoretical basis for the smoking cessation program is motivational interviewing (MI), an established counselling method previously used in smoking cessation programs as well as in other behaviour...
Eligibility Criteria
Inclusion
- Newly diagnosed cancer patients
- Offered radiation, chemo or immuno therapy in a designated hospitals
- Current smokers or recent quitters (within the last six weeks)
- 18 years or older
Exclusion
- Survival prognosis less than 12 months
- Suffering dementia or other mental illnesses
Key Trial Info
Start Date :
September 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT03328962
Start Date
September 15 2017
End Date
June 1 2021
Last Update
August 21 2019
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Ålesund Hospital
Ålesund, Norway
2
Haukeland University Hospital
Bergen, Norway, 5021
3
Nordlandssykehuset
Bodø, Norway, 8092
4
Sørlandet Hospital
Kristiansand, Norway